Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

c-LEcta GmbH. (1/26/17). "Press Release: c-LEcta Starts Marketing & Distribution of Denarase".

Organisations Organisation c-LEcta GmbH
  Organisation 2 Sartorius Stedim Biotech GmbH (SSB)
  Group Sartorius (Group)
Products Product Denarase®
  Product 2 biopharmaceutical
     


DENARASE® is now directly available at c-LEcta. c-LEcta has taken over the product distribution from Sartorius Stedim Biotech GmbH by the end of 2016 and now sells DENARASE® under the same brand name and in identical package sizes. Furthermore, c-LEcta continues to produce the endonuclease in the same production facilities using its patent protected production process in full compliance with cGMP requirements. This process allows to provide DENARASE® in an outstanding product quality and at low prices.

DENARASE® from Serratia marcenses is a highly active nuclease that is used to remove interfering DNA and RNA from fermentation batches e.g. during the production of vaccines and biopharmaceuticals.


The advantages of DENARASE® are:

+ Animal product free production

+ endotoxin-free production strain

+ high purity and activity

+ compliance with cGMP


If you are interested in testing our DENARASE or if you need further information, please do not hesitate to contact us via denarase@c-lecta.com.

   
Record changed: 2017-01-31

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for c-LEcta GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top